Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    12027927 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, Biphasic Insulin Aspart 30, 50 and 70.
Condition: Type 1 Diabetes
Intervention: Drug: NovoRapid, NovoMix 30, Bifasisk Insulin Aspart 50, BIAsp70

Study has passed its completion date and status has not been verified in more than two years.